TABLE 3.
Biological activity of synthetic peptides derived from Apaf-1 CARD phage display
| Peptide | Sequence | IC50a | IC50b |
|---|---|---|---|
| μm | μm | ||
| Phg1 | WPTPPYA | NIc | NI |
| Phg2 | ASLRTLTSLLPA | 92 ± 10 | NI |
| Phg3 | NFMESLPRLGMH | NI | NI |
| Phg4d | Cyclo-CSWFEASYC | 65 ± 7 | 90 ± 10 |
| Phg5d | Cyclo-CLPTLHLLC | NI | NI |
| Phg6 | AHLELRSNNMYF | NI | NI |
a Activity was analyzed in the in vitro reconstituted apoptosome.
b Activity was analyzed in a cell extract-based assay.
c NI, no inhibition found at the peptide concentration range analyzed.
d Peptides Phg4 and Phg5, which contain two Cys residues in the N and the C terminus, were cycled (see “Experimental Procedures”).